CARA: Rega marang dodolan Cara Therapeutics, Inc

Logo korporat perusahaan Cara Therapeutics Inc. (CARA)

Cara Therapeutics, Inc. (CARA) is stagnating due to failed tests and requires a portfolio update. However, niche dominance in the therapy of dialysis patients allows the company to maintain premium pricing. An expansion strategy via B2B partnerships aims for market capture. The current price-to-sales ratio on the GURU.Markets system summary chart reflects sales dynamics, where 15.10 serves as the current parameter value.

CARA: Multiplikator P/S Cara Therapeutics, Inc. 04.07.2022 - 09.05.2026

Rincian analitis perusahaan Cara Therapeutics Inc. (CARA)

Ringkesan analitik perusahaan:CARA Cara Therapeutics, Inc
Barang unggulan Cara Therapeutics

The P/S multiple determines the market value of a business relative to its generated revenue, allowing for an assessment of asset monetization efficiency and the identification of "value trap" risks during price undervaluation. For Cara Therapeutics, Inc. (CARA), the decline in the price-to-sales ratio reflects market skepticism stemming from the termination of clinical phases and the loss of its partner network within the nephrology drug segment.

Karo sapa Cara Therapeutics, Inc. saingan

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Corp)|Regencell Bioscience - Rasio rega marang pendapatan|Axsome Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Rasio rega marang pendapatan|Rega marang dodolan Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Multiplikator P/S|CPRX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DNLI|Koefisien rega marang pendapatan Harmony Biosciences|Biohaven Ltd - Kapitalisasi marang pendapatan|Multiplikator P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Praxis Corp PRAX|AVXL: Multiplikator P/S|CBLL (ceribell.com) - Rasio rega marang pendapatan|PRTA (Prothena Corporation) - Multiplikator P/S|Kapitalisasi marang pendapatan alector.com (ALEC)|Rasio rega marang pendapatan Annexon, Inc. (ANNX)|OMER - Rega marang dodolan|Multiplikator P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rega marang dodolan|Voyager Therapeutics Inc - Multiplikator P/S|Neumora (NMRA) - Kapitalisasi marang pendapatan|SCLX: Multiplikator P/S|TVGN - Koefisien rega marang pendapatan|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan cogrx.com (CGTX)|Rasio rega marang pendapatan Inhibikase Therapeutics Inc (IKT)|Koefisien rega marang pendapatan Cassava Sciences|Multiplikator P/S ASRT (Assertio Holdings)|COYA - Kapitalisasi marang pendapatan|vistagen.com - Multiplikator P/S|OVID: Rasio rega marang pendapatan|Acumen Pharmaceuticals, Inc (ABOS) - Rasio rega marang pendapatan|CervoMed Inc - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alterity Therapeutics Limited|clene.com (CLNN) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan PEPG (PepGen Inc)|Multiplikator P/S jupiterneurosciences.com (JUNS)|Rasio rega marang pendapatan Relmada Therapeutics, Inc. RLMD|ANVS: Rasio kapitalisasi marang pendapatan|Grace Tx - Multiplikator P/S|AIFF (Firefly Neuroscience Inc) - Rasio kapitalisasi marang pendapatan|KLTO: Multiplikator P/S|NeuroSense Therapeutics, Ltd. (NRSN) - Multiplikator P/S|Rasio rega marang pendapatan Reviva Pharmaceuticals, Inc.|Kapitalisasi marang pendapatan metaviatx.com (MTVA)|Multiplikator P/S NRXS|HSDT - Rega marang dodolan|Passage Bio, Inc. - Kapitalisasi marang pendapatan|bionomics.com.au (NEUP) - Rega marang dodolan|Minerva - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ATHA (Athira Pharma Inc)|ADXN: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator P/S|PTIX (Protagenic Therapeutics) - Kapitalisasi marang volume dodolan|Multiplikator P/S KTTA|Koefisien rega marang pendapatan Cortigent|Multiplikator P/S ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang pendapatan|chromocell.com - Multiplikator P/S|Rasio rega marang dodolan ELYM|ITCI: Multiplikator P/S|Rega marang dodolan Longboard Pharmaceuticals, Inc. (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRBO|SAGE: Rasio rega marang dodolan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan